Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12111457rdf:typepubmed:Citationlld:pubmed
pubmed-article:12111457lifeskim:mentionsumls-concept:C1512035lld:lifeskim
pubmed-article:12111457lifeskim:mentionsumls-concept:C0007585lld:lifeskim
pubmed-article:12111457lifeskim:mentionsumls-concept:C0068608lld:lifeskim
pubmed-article:12111457lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12111457lifeskim:mentionsumls-concept:C1407029lld:lifeskim
pubmed-article:12111457pubmed:issue5-6lld:pubmed
pubmed-article:12111457pubmed:dateCreated2002-7-11lld:pubmed
pubmed-article:12111457pubmed:abstractTextIn the present study, primary cultures of mesencephalic dopaminergic cells were exposed to synthetic dopamine neuromelanin (NM) for 48 hrs at concentrations of 0, 1, 10, 20, 50 and 100 microg NM/ml medium. Differently prepared synthetic NM with or without incorporated iron and NM oxidatively damaged by hydrogen peroxide were used. All NMs affected cellular structures e.g. as swelling of neural processes, rounding of cells, and occasional inclusion of neuromelanin particles. Cell numbers were uniformly and dose dependently reduced. Exposure to MPP(+) and ferric iron led to cytotoxic changes which could be further aggravated by oxidatively damaged NM, suggesting cytotoxicity of soluble compounds of NM in predamaged neurons.lld:pubmed
pubmed-article:12111457pubmed:languageenglld:pubmed
pubmed-article:12111457pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:citationSubsetIMlld:pubmed
pubmed-article:12111457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12111457pubmed:statusMEDLINElld:pubmed
pubmed-article:12111457pubmed:monthMaylld:pubmed
pubmed-article:12111457pubmed:issn0300-9564lld:pubmed
pubmed-article:12111457pubmed:authorpubmed-author:GilleGGlld:pubmed
pubmed-article:12111457pubmed:authorpubmed-author:NguyenAAlld:pubmed
pubmed-article:12111457pubmed:authorpubmed-author:MoldzioRRlld:pubmed
pubmed-article:12111457pubmed:authorpubmed-author:RauschW-DWDlld:pubmed
pubmed-article:12111457pubmed:authorpubmed-author:HungS-TSTlld:pubmed
pubmed-article:12111457pubmed:issnTypePrintlld:pubmed
pubmed-article:12111457pubmed:volume109lld:pubmed
pubmed-article:12111457pubmed:ownerNLMlld:pubmed
pubmed-article:12111457pubmed:authorsCompleteYlld:pubmed
pubmed-article:12111457pubmed:pagination651-61lld:pubmed
pubmed-article:12111457pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:meshHeadingpubmed-meshheading:12111457...lld:pubmed
pubmed-article:12111457pubmed:year2002lld:pubmed
pubmed-article:12111457pubmed:articleTitleSynthetic neuromelanin is toxic to dopaminergic cell cultures.lld:pubmed
pubmed-article:12111457pubmed:affiliationInstitute for Medical Chemistry, Veterinary Medical University, Vienna, Austria.lld:pubmed
pubmed-article:12111457pubmed:publicationTypeJournal Articlelld:pubmed